IPO Kite Pharma Inc. (KITE) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
No comments:
Post a Comment